Voronoi, Inc clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-14
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: VRN101099 · HER2-Positive Solid Tumors Primary completion pushed from May 1, 2026 to Mar 1, 2027
- Minor: REACH-EGFR · VRN110755 · EGFR-Mutant Non-Small Cell Lung Cancer Study completion pushed from Jan 1, 2029 to Oct 1, 2029
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 2 | |
| Phase 1/2 | 1 |
Disease areas by active trials
HER2-Positive Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when Voronoi, Inc's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.